Detalhe da pesquisa
1.
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
J Infect Dis
; 218(4): 633-644, 2018 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669026
2.
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition.
J Immunol
; 197(7): 2726-37, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591322
3.
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
J Infect Dis
; 215(8): 1255-1263, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329190
4.
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.
J Infect Dis
; 216(9): 1080-1090, 2017 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968759
5.
Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.
J Immunol
; 193(12): 6172-83, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25398324
6.
Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge.
J Infect Dis
; 211(1): 45-52, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850790
7.
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.
Clin Immunol
; 155(1): 91-107, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25229164
8.
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.
Clin Immunol
; 153(2): 308-22, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24907411
9.
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.
J Virol
; 87(3): 1708-19, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23175374
10.
TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure.
J Virol
; 85(23): 12399-409, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21917950
11.
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial.
Lancet HIV
; 7(4): e238-e248, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035516
12.
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.
Nat Med
; 22(7): 762-70, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27239761
13.
Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.
AIDS Res Hum Retroviruses
; 31(1): 115-26, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24432835
14.
Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac251 infection of macaques.
Virology
; 450-451: 359-68, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24503100
15.
Induction of strong anti-HIV cellular immunity by a combination of Clostridium perfringens expressing HIV gag and virus like particles.
Curr HIV Res
; 9(8): 613-22, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22211658
16.
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.
Nat Med
; 22(10): 1192, 2016 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27711066